テストステロン置換療法の世界市場2016-2020...市場調査レポートについてご紹介

【英文タイトル】Global Testosterone Replacement Therapy Market 2016-2020

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼マーケットレポート

【レポートの概要(一部)】

PART 01: Executive summary
• Highlights

PART 02: Scope of the report
• Market overview
• Top-vendor offerings

PART 03: Market research methodology
• Research methodology
• Economic indicators

PART 04: Introduction
• Key market highlights

PART 05: Hypogonadism
• Understanding Hypergonadism
• Pathophysiology
• Symptoms
• Diagnosis
• Treatment

PART 06: Pipeline analysis
• TESTAVAN
• Vibex QST
• LPCN 1021
• REXTORO
• Enclomiphene
• LPCN 1111
• TSX-002
• TEFINA
• THG-1001
• MetP Testosterone Nasal Gel

PART 07: Key buying criteria

PART 08: Market landscape
• Global endocrinology drugs market
• Global testosterone replacement therapy market
• Five forces analysis

PART 09: Market segmentation by dosage form
• Gels
• Injectables
• Patches
• Others

PART 10: Geographical segmentation
• Global testosterone replacement therapy market by geography 2015-2020
• Testosterone replacement therapy market in Americas
• Testosterone replacement therapy market in EMEA
• Testosterone replacement therapy market in APAC

PART 11: Market drivers
• Increase in older population
• High incidence of testosterone deficiency
• Rise in chronic diseases
• Increase in awareness

PART 12: Impact of drivers

PART 13: Market challenges
• Generic erosion
• FDA warnings on use of testosterone products
• Adverse effects
• Physicians are reluctant to prescribe medications with testosterone
• Reluctance to discuss condition

PART 14: Impact of drivers and challenges

PART 15: Market trends
• Entry of SARMs
• Support of patient assistance programs
• Focus on emerging markets
• Application in new therapeutic indications

PART 16: Vendor landscape
• Competitive scenario
• Market analysis 2015
• AbbVie
• Allergan
• Eli Lilly
• Endo International
• Other prominent vendors

PART 17: Appendix
• List of abbreviations

PART 18: Explore Technavio

[List of Exhibits]

Exhibit 01: Product offerings
Exhibit 02: Normal levels of testosterone based on gender
Exhibit 03: Normal levels of testosterone at different ages
Exhibit 04: Timeline of testosterone replacement therapy products
Exhibit 05: Advantages and risks associated with use of testosterone products
Exhibit 06: Causes of hypogonadism
Exhibit 07: Symptoms of hypogonadism
Exhibit 08: Diagnostic algorithm of hypogonadism
Exhibit 09: Pipeline portfolio: Global testosterone drugs market
Exhibit 10: Key buying criteria for testosterone replacement therapy
Exhibit 11: Global endocrinology drugs market 2015-2020 ($ billions)
Exhibit 12: Market share of global testosterone replacement therapy market in global endocrinology drugs market
Exhibit 13: Global testosterone replacement therapy market 2015-2020 ($ billions)
Exhibit 14: Five forces analysis
Exhibit 15: Global testosterone replacement therapy market by dosage form 2015
Exhibit 16: Segmentation of global testosterone replacement therapy market based on geography 2015
Exhibit 17: Global testosterone replacement therapy market by geography 2015-2020 ($ billions)
Exhibit 18: Global testosterone replacement therapy market by geography 2015-2020
Exhibit 19: Testosterone replacement therapy market in Americas 2015-2020 ($ billions)
Exhibit 20: Percentage share of US in testosterone replacement therapy market 2015
Exhibit 21: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 22: Testosterone replacement therapy market in EMEA 2015-2020 ($ billions)
Exhibit 23: Global testosterone replacement therapy market: YoY growth and revenue based on geography 2015-2020
Exhibit 24: Impact of drivers
Exhibit 25: Impact of drivers and challenges
Exhibit 26: AbbVie: YoY revenue and growth rate of AndroGel 2013-2015 ($ billions)
Exhibit 27: AbbVie: Key takeaways
Exhibit 28: Allergan: Key takeaways
Exhibit 29: Eli Lilly: YoY revenue and growth rate of Axiron 2013-2015 ($ millions)
Exhibit 30: Geographical segmentation of Axiron by revenue 2015
Exhibit 31: Eli Lilly: Key takeaways
Exhibit 32: Endo International: YoY revenue and growth rate of Fortesta 2013-2015 ($ millions)
Exhibit 33: Endo: Key takeaways


【レポート販売概要】

■ タイトル:テストステロン置換療法の世界市場2016-2020
■ 英文:Global Testosterone Replacement Therapy Market 2016-2020
■ 発行日:2016年7月27日
■ 調査会社:Technavio
■ 商品コード:IRTNTR9274
■ 調査対象地域:グローバル
※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。